Biosporin (Tablets, Lyophilisate) Instructions for Use

ATC Code

A07FA (Antidiarrheal microorganisms)

Clinical-Pharmacological Group

Drug regulating the balance of intestinal and vaginal microflora

Pharmacotherapeutic Group

MIBP-eubiotic

Pharmacological Action

The bacteria that are part of the drug have high antagonistic activity against pathogenic and opportunistic microorganisms and do not affect representatives of the normal microflora.

They synthesize a complex of enzymes that stimulate and regulate digestion.

Indications

Acute intestinal infections caused by pathogenic and opportunistic microorganisms (Salmonella, Shigella, enteropathogenic Escherichia coli, Proteus, Staphylococcus, Candida), including antibiotic-resistant ones: in mild and moderate diseases; in severe forms in persons with contraindications to antibiotics; isolation of pathogenic and opportunistic microorganisms or gastrointestinal dysfunction after acute intestinal infections; intestinal dysbiosis of various etiologies, including against the background of antibiotic therapy; prevention of postoperative infections, including purulent-septic complications; vulvovaginal candidiasis, bacterial vaginosis in women of reproductive age, including pregnant women (after completion of a course of antibacterial therapy).

ICD codes

Dosage Regimen

Tablets, Lyophilisate

Orally, with boiled water, 30-40 minutes before meals. Crushing the tablet is allowed.

In children: for treatment of acute intestinal infections (including dysentery, salmonellosis, food toxicoinfection) 1 dose 2 times/day for 5-7 days; for follow-up treatment of convalescents after acute intestinal infections – 1 dose 2 times/day for 5 days, if necessary, the course of treatment can be extended to 2 weeks; for intestinal dysbiosis – 1 dose 2 times/day for 10-14 days; for prevention of purulent-septic complications in the postoperative period 1 dose 2 times/day for 5-7 days before surgery and for 10 days after surgery.

In adults: acute intestinal infections – 2 doses 3 times/day for 5-7 days; for follow-up treatment of convalescents after acute intestinal infections – 2 doses 3 times/day for 5 days, if necessary, the course of treatment can be extended to 2 weeks; for intestinal dysbiosis – 2 doses 2 times/day for 10-14 days; for prevention of purulent-septic complications in the postoperative period – 2 doses 2 times/day for 5-7 days before surgery and for 10 days after surgery; vulvovaginal candidiasis and bacterial vaginosis – 2 doses 2 times/day for 7-10 days. If necessary, the course of treatment can be repeated.

Adverse Reactions

Not established.

Contraindications

Hypersensitivity to the components of the drug.

Pediatric Use

Use is possible according to the dosing regimen.

Storage Conditions

Store at 2°C (36°F) to 30°C (86°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.